Skip to content

MyHealtheVet to Enable Shared Decision Making Regarding Menopausal in Postmenopausal Women Veterans (MEANS)

MyHealtheVet to Enable Shared Decision Making Regarding Menopausal and Associated Symptoms in Postmenopausal Women Veterans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03109145
Acronym
MEANS
Enrollment
859
Registered
2017-04-12
Start date
2014-10-31
Completion date
2020-01-31
Last updated
2021-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopause

Keywords

Shared decision making, Knowledge, Patient portal, Secure messaging

Brief summary

The purpose of this research study is to examine the impact of educational secure messages on menopause. In particular, the investigators will examine whether the secure messages increase menopause knowledge and communication between patients and their providers.

Detailed description

The overall goal of this project is to determine the effectiveness of the MEANS (MyHealtheVet to Enable And Negotiate for Shared decision making) intervention in improving women's self-reported knowledge and rates of diagnosis and appropriate management of menopause symptoms. The proposed intervention is an educational and shared decision making platform for menopause symptoms to improve communication between patients and their providers regarding menopause symptoms. MEANS combines educational secure messages through the Veterans Affairs online Personal Health Record called MyHealtheVet, along with face-to-face and print interventions. MEANS will be applied in target population consisting of postmenopausal women Veterans ages 45 to 60 who receive primary care at the Miami Veterans Affairs Healthcare System. This project will enroll women in MyHealtheVet, develop a library of menopause symptoms material for distribution, and evaluate how useful of MyHealtheVet use for educating and tracking women regarding menopause symptoms.

Interventions

OTHERMenopause educational secure messaging

Participants read educational material about menopause and treatment option for menopause symptoms once a week using secure messaging on a electronic patient portal.

Sponsors

Pfizer
CollaboratorINDUSTRY
Miami VA Healthcare System
Lead SponsorFED

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
45 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Women Veterans, age 45-60 * Receive primary care at the Miami Veterans Affairs Healthcare System * Able to communicate in English * Already or willing to register and become authenticated in the patient health portal, MyHealtheVet. * Able to use read, understand, and respond to secure messages using patient health portal.

Exclusion criteria

* Not willing to register and become authenticated for patient health portal. * Not willing to receive educational secure messages from patient health portal.

Design outcomes

Primary

MeasureTime frameDescription
Menopause Knowledge6-monthsTotal menopause knowledge score (a) before and after the intervention, an average of 6-months and (b) compared to a control group of eligible women patients between 45-60 years who do not receive the intervention at the West Palm Beach and Orlando Veterans Healthcare System. Score is the percent of knowledge questions answered correctly (0 - 100%)
Feasibility of patient portal use for educating and tracking women regarding menopause and menopause related symptoms.6-monthsThe study will send weekly secure messages regarding menopause, and ask participants to report their menopause related symptoms by secure messaging. The research study will track the number of times participants read the weekly information sent via MyHealtheVet and the proportion of times they respond.

Secondary

MeasureTime frameDescription
Shared decision makingThrough study completion, an average of 3-yearsSelf-reported rate of shared decision making among women veteran and their providers.
Menopause related diagnosisThrough study completion, an average of 3-yearsRates of diagnosis and appropriate management of menopause related symptoms and use of hormone therapy.
Focus Group6-monthsQualitative assessment of the interventions through participant semi-structure focus group interviews.
Patient portal registration and authenticationThrough study completion, an average of 3-yearsMeasure the number of eligible women patients in the Miami Veterans Healthcare System who are enrolled and authenticated in the patient portal before and after the intervention.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026